Allogeneic Stem Cell Market - Growth, Future Prospects and Competitive Analysis, 2023

Description

List of Tables

The allogeneic stem cell market stands at the forefront of regenerative medicine, offering remarkable promise for the treatment of various diseases. The allogeneic stem cell market is expected to grow at a CAGR of 6.5% during the forecast period of 2023 to 2031, driven by advancements in unmodified stem cell transplants, expanding applications in oncology, and emerging therapies for musculoskeletal diseases. Despite the restraint of graft-versus-host disease, the market demonstrates promise in addressing various medical conditions. Market segmentation by type and application highlights areas of significant growth, and geographic trends underline the regional variations in demand. Competitive players are actively engaged in research, innovation, and partnerships to meet the growing demand for allogeneic stem cell therapies. The Allogeneic Stem Cell market is set to shape the future of regenerative medicine and significantly impact the healthcare landscape.

Advancements in Unmodified Stem Cell Transplants

One of the primary drivers propelling the Allogeneic Stem Cell market is the continuous advancement in unmodified stem cell transplants. The market has witnessed a surge in the development of more effective and reliable methods for harvesting, processing, and transplanting unmodified allogeneic stem cells. These unmodified stem cell transplants have been increasingly used in various applications, including treating musculoskeletal diseases, cardiovascular diseases, autoimmune diseases, and oncology.

Expanding Applications in Oncology

The Allogeneic Stem Cell market has been significantly driven by the expanding applications of stem cell transplants in oncology. The use of allogeneic stem cells has shown remarkable success in treating various forms of cancer, such as leukemia, lymphoma, and myeloma. The adoption of these treatments has led to better outcomes for cancer patients and a growing acceptance of stem cell therapies in the oncology field.

Emerging Therapies for Musculoskeletal Diseases

The market has seen substantial growth due to the emergence of advanced therapies for musculoskeletal diseases. Allogeneic stem cell transplants have showcased their potential in treating orthopedic conditions, including joint degeneration, spinal injuries, and musculoskeletal disorders. The regenerative properties of allogeneic stem cells have opened new avenues for treating musculoskeletal issues, reducing pain, and improving the quality of life for patients.

Restraint in the Allogeneic Stem Cell Market

One of the primary restraints in the Allogeneic Stem Cell market is the risk of graft-versus-host disease (GvHD) associated with allogeneic stem cell transplants. GvHD is a severe condition where the donor's immune cells attack the recipient's tissues and organs. Although advances have been made in T-cell depletion techniques and cord blood transplants to minimize the risk, it remains a significant concern, especially in unmodified stem cell transplants.

Market Segmentation by Type (Unmodified Stem Cell Transplant, T-cell depleted Transplant, Cord Blood Transplant, Donor Lymphocyte Infusion): T-cell depleted Transplant Dominates the Market

The Allogeneic Stem Cell market can be segmented by type into four categories: Unmodified Stem Cell Transplant, T-cell depleted Transplant, Cord Blood Transplant, and Donor Lymphocyte Infusion. In 2022, "T-cell depleted Transplant" generated the highest revenue, mainly due to its effective approach in reducing the risk of graft-versus-host disease. For the period from 2023 to 2031, "Cord Blood Transplant" is expected to exhibit the highest compound annual growth rate (CAGR). Cord blood transplants offer a promising source of stem cells and are increasingly being explored for various applications in regenerative medicine.

Market Segmentation by Application (Musculoskeletal Disease, Cardiovascular Disease, Autoimmune Disease, Oncology, GvHD, Others): Oncology Segment Dominates the Market

The Allogeneic Stem Cell market can be segmented by application into six categories: Musculoskeletal Disease, Cardiovascular Disease, Autoimmune Disease, Oncology, GvHD, and Others, including neuro disorders and pulmonary diseases. In 2022, "Oncology" generated the highest revenue, as stem cell transplants have shown substantial success in treating various forms of cancer. For the period from 2023 to 2031, "Musculoskeletal Disease" is expected to experience the highest CAGR. The emerging therapies and regenerative potential of allogeneic stem cells in addressing orthopedic and musculoskeletal issues are driving this growth.

North America Remains the Global Leader

The Allogeneic Stem Cell market exhibits significant geographic variations in demand and growth. Geographic trends indicate that North America, with its well-established healthcare infrastructure and advanced research capabilities, has been a prominent market for allogeneic stem cell therapies. Europe and Asia-Pacific are also witnessing significant growth, driven by increasing healthcare investments and expanding applications. In terms of the region with the highest CAGR during the forecast period from 2023 to 2031, Asia-Pacific is expected to experience substantial growth. The region's growing healthcare sector, increasing prevalence of chronic diseases, and expanding research activities contribute to its prominence in the market. Regarding revenue percentage, North America is anticipated to maintain its position as the region with the highest revenue percentage throughout the forecast period. The region's leadership in medical research, robust healthcare infrastructure, and patient access to advanced therapies support its continued dominance in the market.

Market Competition to Intensify during the Forecast Period

The Allogeneic Stem Cell market features several prominent players, including but not limited to:

Fresenius Kabi AG: Fresenius Kabi is a key player in the Allogeneic Stem Cell market, with a focus on developing innovative transplant solutions and expanding its global presence. The company's strategy includes collaborations with research institutions and healthcare organizations to advance stem cell therapies.

Regeneron Pharmaceuticals, Inc.: Regeneron Pharmaceuticals is actively involved in the research and development of allogeneic stem cell therapies, particularly in the field of oncology. The company's strategy includes investments in clinical trials, regulatory approvals, and strategic partnerships.

Novartis International AG: Novartis is a global pharmaceutical giant actively engaged in advancing allogeneic stem cell treatments for various diseases. The company's strategy involves a strong commitment to research and development, market expansion, and addressing the safety and efficacy of allogeneic stem cell therapies.

Sanofi: Sanofi has a significant presence in the Allogeneic Stem Cell market, with a focus on autoimmune disease treatments. The company's strategy includes product innovation, clinical trials, and partnerships with healthcare providers.

Mesa Biotech, Inc.: Mesa Biotech is a notable player in the Allogeneic Stem Cell market, with a focus on point-of-care diagnostic solutions for stem cell therapies. The company's strategy involves technological advancements, accessibility, and affordability.

The key strategies adopted by these players include continuous research and development efforts, partnerships with academic and research institutions, clinical trials, regulatory compliance, and expansion into emerging markets. These strategies align with the growing demand for allogeneic stem cell therapies and the need to address complex medical conditions effectively.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofAllogeneic Stem Cell market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Allogeneic Stem Cell market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Type

Unmodified Stem Cell Transplant

T-cell depleted Transplant

Cord Blood Transplant

Donor Lymphocyte Infusion (DLI)

Cell Source

Bone Marrow

Peripheral Blood Stem Cell (PBSC)

Umbilical Cord Blood

Adipose Tissue

Others (Placenta)

Application

Musculoskeletal Disease

Cardiovascular Disease

Autoimmune Disease

Oncology

GvHD

Others (Neuro Disorder and Pulmonary Disease)

End-User

Hospital

Ambulatory Surgical Center

Others (Cancer Center and Research Institute)

Region Segment (2021-2031; US$ Million)

North America
U.S.
Canada
Rest of North America
UK and European Union
UK
Germany
Spain
Italy
France
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC
Africa
Rest of Middle East and Africa

Key questions answered in this report:

What are the key micro and macro environmental factors that are impacting the growth of Allogeneic Stem Cell market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Allogeneic Stem Cell market?

Which is the largest regional market for Allogeneic Stem Cell market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Allogeneic Stem Cell market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Allogeneic Stem Cell market worldwide?

Product Code: 139953-11-23

1. Preface

1.1. Report Description
- 1.1.1. Purpose of the Report
- 1.1.2. Target Audience
- 1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
- 1.3.1. Phase I - Secondary Research
- 1.3.2. Phase II - Primary Research
- 1.3.3. Phase III - Expert Panel Review
- 1.3.4. Assumptions
- 1.3.5. Approach Adopted

2. Executive Summary

2.1. Market Snapshot: Global Allogeneic Stem Cell Market
2.2. Global Allogeneic Stem Cell Market, By Type, 2022 (US$ Million)
2.3. Global Allogeneic Stem Cell Market, By Cell Source, 2022 (US$ Million)
2.4. Global Allogeneic Stem Cell Market, By Application, 2022 (US$ Million)
2.5. Global Allogeneic Stem Cell Market, By End-User, 2022 (US$ Million)
2.6. Global Allogeneic Stem Cell Market, By Geography, 2022 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2022

3. Allogeneic Stem Cell Market: Competitive Analysis

3.1. Market Positioning of Key Allogeneic Stem Cell Market Vendors
3.2. Strategies Adopted by Allogeneic Stem Cell Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031

4. Allogeneic Stem Cell Market: Macro Analysis & Market Dynamics

4.1. Introduction
4.2. Global Allogeneic Stem Cell Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
- 4.3.1. Market Drivers
- 4.3.2. Market Restraints
- 4.3.3. Key Challenges
- 4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
- 4.6.1. Supplier Power
- 4.6.2. Buyer Power
- 4.6.3. Threat Of Substitutes
- 4.6.4. Threat Of New Entrants
- 4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
- 4.7.1. Political Landscape
- 4.7.2. Economic Landscape
- 4.7.3. Technology Landscape
- 4.7.4. Legal Landscape
- 4.7.5. Social Landscape

5. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)

5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
- 5.3.1. Unmodified Stem Cell Transplant
- 5.3.2. T-cell depleted Transplant
- 5.3.3. Cord Blood Transplant
- 5.3.4. Donor Lymphocyte Infusion (DLI)

6. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)

6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
- 6.3.1. Bone Marrow
- 6.3.2. Peripheral Blood Stem Cell (PBSC)
- 6.3.3. Umbilical Cord Blood
- 6.3.4. Adipose Tissue
- 6.3.5. Others (Placenta)

7. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)

7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
- 7.3.1. Musculoskeletal Disease
- 7.3.2. Cardiovascular Disease
- 7.3.3. Autoimmune Disease
- 7.3.4. Oncology
- 7.3.5. GvHD
- 7.3.6. Others (Neuro Disorder and Pulmonary Disease)

8. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)

8.1. Market Overview
8.2. Growth & Revenue Analysis: 2022 Versus 2031
8.3. Market Segmentation
- 8.3.1. Hospital
- 8.3.2. Ambulatory Surgical Center
- 8.3.3. Others (Cancer Center and Research Institute)

9. North America Allogeneic Stem Cell Market, 2021-2031, USD (Million)

9.1. Market Overview
9.2. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
9.3. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
9.4. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
9.5. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
9.6.Allogeneic Stem Cell Market: By Region, 2021-2031, USD (Million)
- 9.6.1.North America
  - 9.6.1.1. U.S.
    - 9.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 9.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 9.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 9.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 9.6.1.2. Canada
    - 9.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 9.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 9.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 9.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 9.6.1.3. Rest of North America
    - 9.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 9.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 9.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 9.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)

10. UK and European Union Allogeneic Stem Cell Market, 2021-2031, USD (Million)

10.1. Market Overview
10.2. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
10.3. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
10.4. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
10.5. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
10.6.Allogeneic Stem Cell Market: By Region, 2021-2031, USD (Million)
- 10.6.1.UK and European Union
  - 10.6.1.1. UK
    - 10.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 10.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 10.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 10.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 10.6.1.2. Germany
    - 10.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 10.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 10.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 10.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 10.6.1.3. Spain
    - 10.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 10.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 10.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 10.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 10.6.1.4. Italy
    - 10.6.1.4.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 10.6.1.4.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 10.6.1.4.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 10.6.1.4.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 10.6.1.5. France
    - 10.6.1.5.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 10.6.1.5.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 10.6.1.5.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 10.6.1.5.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 10.6.1.6. Rest of Europe
    - 10.6.1.6.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 10.6.1.6.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 10.6.1.6.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 10.6.1.6.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)

11. Asia Pacific Allogeneic Stem Cell Market, 2021-2031, USD (Million)

11.1. Market Overview
11.2. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
11.3. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
11.4. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
11.5. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
11.6.Allogeneic Stem Cell Market: By Region, 2021-2031, USD (Million)
- 11.6.1.Asia Pacific
  - 11.6.1.1. China
    - 11.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 11.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 11.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 11.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 11.6.1.2. Japan
    - 11.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 11.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 11.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 11.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 11.6.1.3. India
    - 11.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 11.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 11.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 11.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 11.6.1.4. Australia
    - 11.6.1.4.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 11.6.1.4.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 11.6.1.4.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 11.6.1.4.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 11.6.1.5. South Korea
    - 11.6.1.5.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 11.6.1.5.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 11.6.1.5.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 11.6.1.5.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 11.6.1.6. Rest of Asia Pacific
    - 11.6.1.6.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 11.6.1.6.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 11.6.1.6.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 11.6.1.6.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)

12. Latin America Allogeneic Stem Cell Market, 2021-2031, USD (Million)

12.1. Market Overview
12.2. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
12.3. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
12.4. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
12.5. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
12.6.Allogeneic Stem Cell Market: By Region, 2021-2031, USD (Million)
- 12.6.1.Latin America
  - 12.6.1.1. Brazil
    - 12.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 12.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 12.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 12.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 12.6.1.2. Mexico
    - 12.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 12.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 12.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 12.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 12.6.1.3. Rest of Latin America
    - 12.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 12.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 12.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 12.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)

13. Middle East and Africa Allogeneic Stem Cell Market, 2021-2031, USD (Million)

13.1. Market Overview
13.2. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
13.3. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
13.4. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
13.5. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
13.6.Allogeneic Stem Cell Market: By Region, 2021-2031, USD (Million)
- 13.6.1.Middle East and Africa
  - 13.6.1.1. GCC
    - 13.6.1.1.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 13.6.1.1.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 13.6.1.1.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 13.6.1.1.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 13.6.1.2. Africa
    - 13.6.1.2.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 13.6.1.2.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 13.6.1.2.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 13.6.1.2.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)
  - 13.6.1.3. Rest of Middle East and Africa
    - 13.6.1.3.1. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)
    - 13.6.1.3.2. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)
    - 13.6.1.3.3. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)
    - 13.6.1.3.4. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)

14. Company Profile

14.1. Fresenius Kabi AG
- 14.1.1. Company Overview
- 14.1.2. Financial Performance
- 14.1.3. Product Portfolio
- 14.1.4. Strategic Initiatives
14.2. Regeneron Pharmaceuticals, Inc.
- 14.2.1. Company Overview
- 14.2.2. Financial Performance
- 14.2.3. Product Portfolio
- 14.2.4. Strategic Initiatives
14.3. Novartis International AG
- 14.3.1. Company Overview
- 14.3.2. Financial Performance
- 14.3.3. Product Portfolio
- 14.3.4. Strategic Initiatives
14.4. Sanofi
- 14.4.1. Company Overview
- 14.4.2. Financial Performance
- 14.4.3. Product Portfolio
- 14.4.4. Strategic Initiatives
14.5. Mesa Biotech, Inc.
- 14.5.1. Company Overview
- 14.5.2. Financial Performance
- 14.5.3. Product Portfolio
- 14.5.4. Strategic Initiatives
14.6. Mesoblast Limited
- 14.6.1. Company Overview
- 14.6.2. Financial Performance
- 14.6.3. Product Portfolio
- 14.6.4. Strategic Initiatives
14.7. Gamida Cell Ltd.
- 14.7.1. Company Overview
- 14.7.2. Financial Performance
- 14.7.3. Product Portfolio
- 14.7.4. Strategic Initiatives
14.8. Cellectis SA
- 14.8.1. Company Overview
- 14.8.2. Financial Performance
- 14.8.3. Product Portfolio
- 14.8.4. Strategic Initiatives
14.9. Magenta Therapeutics Inc.
- 14.9.1. Company Overview
- 14.9.2. Financial Performance
- 14.9.3. Product Portfolio
- 14.9.4. Strategic Initiatives
14.10. Fate Therapeutics Inc.
- 14.10.1. Company Overview
- 14.10.2. Financial Performance
- 14.10.3. Product Portfolio
- 14.10.4. Strategic Initiatives
14.11. Cynata Therapeutics Limited
- 14.11.1. Company Overview
- 14.11.2. Financial Performance
- 14.11.3. Product Portfolio
- 14.11.4. Strategic Initiatives
14.12. Kiadis Pharma N.V.
- 14.12.1. Company Overview
- 14.12.2. Financial Performance
- 14.12.3. Product Portfolio
- 14.12.4. Strategic Initiatives
14.13. Takeda Pharmaceutical Company Limited
- 14.13.1. Company Overview
- 14.13.2. Financial Performance
- 14.13.3. Product Portfolio
- 14.13.4. Strategic Initiatives
14.14. JCR Pharmaceuticals Co., Ltd.
- 14.14.1. Company Overview
- 14.14.2. Financial Performance
- 14.14.3. Product Portfolio
- 14.14.4. Strategic Initiatives
14.15. Pluristem Therapeutics Inc.
- 14.15.1. Company Overview
- 14.15.2. Financial Performance
- 14.15.3. Product Portfolio
- 14.15.4. Strategic Initiatives
14.16. Celularity Inc.
- 14.16.1. Company Overview
- 14.16.2. Financial Performance
- 14.16.3. Product Portfolio
- 14.16.4. Strategic Initiatives
14.17. Lineage Cell Therapeutics Inc.
- 14.17.1. Company Overview
- 14.17.2. Financial Performance
- 14.17.3. Product Portfolio
- 14.17.4. Strategic Initiatives
14.18. Nohla Therapeutics Inc.
- 14.18.1. Company Overview
- 14.18.2. Financial Performance
- 14.18.3. Product Portfolio
- 14.18.4. Strategic Initiatives
14.19. Orchard Therapeutics plc
- 14.19.1. Company Overview
- 14.19.2. Financial Performance
- 14.19.3. Product Portfolio
- 14.19.4. Strategic Initiatives
14.20. Other Notable Players
- 14.20.1. Company Overview
- 14.20.2. Financial Performance
- 14.20.3. Product Portfolio
- 14.20.4. Strategic Initiatives

Product Code: 139953-11-23

List of Tables

TABLE 1 Global Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 2 Global Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 3 Global Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 4 Global Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 5 North America Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 6 North America Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 7 North America Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 8 North America Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 9 U.S. Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 10 U.S. Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 11 U.S. Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 12 U.S. Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 13 Canada Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 14 Canada Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 15 Canada Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 16 Canada Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 17 Rest of North America Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 18 Rest of North America Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 19 Rest of North America Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 20 Rest of North America Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 21 UK and European Union Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 22 UK and European Union Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 23 UK and European Union Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 24 UK and European Union Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 25 UK Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 26 UK Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 27 UK Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 28 UK Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 29 Germany Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 30 Germany Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 31 Germany Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 32 Germany Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 33 Spain Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 34 Spain Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 35 Spain Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 36 Spain Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 37 Italy Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 38 Italy Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 39 Italy Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 40 Italy Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 41 France Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 42 France Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 43 France Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 44 France Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 45 Rest of Europe Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 46 Rest of Europe Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 47 Rest of Europe Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 48 Rest of Europe Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 49 Asia Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 50 Asia Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 51 Asia Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 52 Asia Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 53 China Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 54 China Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 55 China Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 56 China Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 57 Japan Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 58 Japan Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 59 Japan Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 60 Japan Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 61 India Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 62 India Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 63 India Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 64 India Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 65 Australia Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 66 Australia Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 67 Australia Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 68 Australia Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 69 South Korea Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 70 South Korea Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 71 South Korea Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 72 South Korea Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 73 Latin America Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 74 Latin America Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 75 Latin America Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 76 Latin America Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 77 Brazil Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 78 Brazil Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 79 Brazil Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 80 Brazil Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 81 Mexico Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 82 Mexico Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 83 Mexico Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 84 Mexico Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 85 Rest of Latin America Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 86 Rest of Latin America Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 87 Rest of Latin America Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 88 Rest of Latin America Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 89 Middle East and Africa Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 90 Middle East and Africa Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 91 Middle East and Africa Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 92 Middle East and Africa Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 93 GCC Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 94 GCC Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 95 GCC Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 96 GCC Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 97 Africa Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 98 Africa Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 99 Africa Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 100 Africa Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)
TABLE 101 Rest of Middle East and Africa Allogeneic Stem Cell Market By Type, 2021-2031, USD (Million)
TABLE 102 Rest of Middle East and Africa Allogeneic Stem Cell Market By Cell Source, 2021-2031, USD (Million)
TABLE 103 Rest of Middle East and Africa Allogeneic Stem Cell Market By Application, 2021-2031, USD (Million)
TABLE 104 Rest of Middle East and Africa Allogeneic Stem Cell Market By End-User, 2021-2031, USD (Million)

List of Figures

FIG. 1 Global Allogeneic Stem Cell Market: Market Coverage
FIG. 2 Research Methodology and Data Sources
FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
FIG. 4 Global Allogeneic Stem Cell Market: Quality Assurance
FIG. 5 Global Allogeneic Stem Cell Market, By Type, 2022
FIG. 6 Global Allogeneic Stem Cell Market, By Cell Source, 2022
FIG. 7 Global Allogeneic Stem Cell Market, By Application, 2022
FIG. 8 Global Allogeneic Stem Cell Market, By End-User, 2022
FIG. 9 Global Allogeneic Stem Cell Market, By Geography, 2022
FIG. 10 Market Geographical Opportunity Matrix - Global Allogeneic Stem Cell Market, 2022

FIG. 11Market Positioning of Key Allogeneic Stem Cell Market Players, 2022

FIG. 12Global Allogeneic Stem Cell Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

FIG. 13 Global Allogeneic Stem Cell Market, By Type, 2022 Vs 2031, %
FIG. 14 Global Allogeneic Stem Cell Market, By Cell Source, 2022 Vs 2031, %
FIG. 15 Global Allogeneic Stem Cell Market, By Application, 2022 Vs 2031, %
FIG. 16 Global Allogeneic Stem Cell Market, By End-User, 2022 Vs 2031, %
FIG. 17 U.S. Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 18 Canada Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 19 Rest of North America Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 20 UK Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 21 Germany Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 22 Spain Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 23 Italy Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 24 France Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 25 Rest of Europe Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 26 China Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 27 Japan Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 28 India Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 29 Australia Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 30 South Korea Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 31 Rest of Asia Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 32 Brazil Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 33 Mexico Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 34 Rest of Latin America Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 35 GCC Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 36 Africa Allogeneic Stem Cell Market (US$ Million), 2021 - 2031
FIG. 37 Rest of Middle East and Africa Allogeneic Stem Cell Market (US$ Million), 2021 - 2031

Allogeneic Stem Cell Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031

Description

Table of Contents

List of Tables

Advancements in Unmodified Stem Cell Transplants

Expanding Applications in Oncology

Emerging Therapies for Musculoskeletal Diseases

Restraint in the Allogeneic Stem Cell Market

Market Segmentation by Type (Unmodified Stem Cell Transplant, T-cell depleted Transplant, Cord Blood Transplant, Donor Lymphocyte Infusion): T-cell depleted Transplant Dominates the Market

Market Segmentation by Application (Musculoskeletal Disease, Cardiovascular Disease, Autoimmune Disease, Oncology, GvHD, Others): Oncology Segment Dominates the Market

North America Remains the Global Leader

Market Competition to Intensify during the Forecast Period

The Allogeneic Stem Cell market features several prominent players, including but not limited to:

Historical & Forecast Period

Research Methodology

Geographical revenues generate by countries considered in the report:

Market Segmentation

Type

Cell Source

Application

End-User

Region Segment (2021-2031; US$ Million)

Key questions answered in this report:

Table of Contents

1. Preface

2. Executive Summary

3. Allogeneic Stem Cell Market: Competitive Analysis

4. Allogeneic Stem Cell Market: Macro Analysis & Market Dynamics

5. Allogeneic Stem Cell Market: By Type, 2021-2031, USD (Million)

6. Allogeneic Stem Cell Market: By Cell Source, 2021-2031, USD (Million)

7. Allogeneic Stem Cell Market: By Application, 2021-2031, USD (Million)

8. Allogeneic Stem Cell Market: By End-User, 2021-2031, USD (Million)

9. North America Allogeneic Stem Cell Market, 2021-2031, USD (Million)

10. UK and European Union Allogeneic Stem Cell Market, 2021-2031, USD (Million)

11. Asia Pacific Allogeneic Stem Cell Market, 2021-2031, USD (Million)

12. Latin America Allogeneic Stem Cell Market, 2021-2031, USD (Million)

13. Middle East and Africa Allogeneic Stem Cell Market, 2021-2031, USD (Million)

14. Company Profile

List of Tables

List of Figures